← Evidence map

ArticlePharmacoEconomics2014

Should off-label drugs be included as comparators in pharmacoeconomic studies?

Surrey M Walton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2014
2015
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25270597